Evaluation of Combination Treatment Benefits of nab-Paclitaxel in Experimental Pancreatic Cancer

被引：0
|
作者：
Awasthi, N. [1 ]
Ostapoff, K. T. [1 ]
Zhang, C. [1 ]
Schwarz, M. A. [1 ]
Schwarz, R. E. [1 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2012年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S153 / S153
页数：1
相关论文
共 50 条
  • [1] Evaluation of combination treatment benefits of nab-paclitaxel in experimental pancreatic cancer.
    Awasthi, Niranjan
    Ostapoff, Katherine
    Zhang, Changhua
    Schwarz, Margaret A.
    Schwarz, Roderich
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [2] nab-Paclitaxel for the treatment of pancreatic cancer
    Kim, George
    CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 85 - 96
  • [3] Gemcitabine and nab-paclitaxel combination therapy for the treatment of metastatic pancreatic cancer
    Sasaki, Takashi
    Kanata, Ryo
    Saito, Kei
    Yamada, Ikuhiro
    Matsuyama, Masato
    Ozaka, Masato
    Takano, Kouichi
    Sasahira, Naoki
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Nab-paclitaxel: potential for the treatment of advanced pancreatic cancer
    Al-Hajeili, Marwan
    Azmi, Asfar S.
    Choi, Minsig
    ONCOTARGETS AND THERAPY, 2014, 7 : 187 - 192
  • [5] nab-Paclitaxel: Novel Clinical and Experimental Evidence in Pancreatic Cancer
    Neesse, A.
    Michl, P.
    Tuveson, D. A.
    Ellenrieder, V.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (04): : 360 - 366
  • [6] EFFICACY AND SAFETY OF NAB-PACLITAXEL IN COMBINATION WITH GEMCITABINE FOR METASTATIC PANCREATIC CANCER
    You, Min Su
    Ryu, Ji Kon
    Kang, Jinwoo
    Choi, Jin Ho
    Choi, Young Hoon
    Huh, Gunn
    Paik, Woo Hyun
    Lee, Sang Hyub
    Kim, Yong-Tae
    GASTROENTEROLOGY, 2018, 154 (06) : S285 - S285
  • [7] Effect of nab-paclitaxel combination chemotherapy on response and survival in pancreatic cancer
    Dean, Andrew Peter
    Cooray, Prasad
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer
    Borazanci, Erkut
    Von Hoff, Daniel D.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (07) : 739 - 747
  • [9] Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer
    Mahipal, Amit
    Tella, Sri Harsha
    Kommalapati, Anuhya
    Goyal, Gaurav
    Soares, Heloisa
    Neuger, Anthony
    Copolla, Domenico
    Kim, Jongphil
    Kim, Richard
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (03) : 473 - 481
  • [10] Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer
    Amit Mahipal
    Sri Harsha Tella
    Anuhya Kommalapati
    Gaurav Goyal
    Heloisa Soares
    Anthony Neuger
    Domenico Copolla
    Jongphil Kim
    Richard Kim
    Investigational New Drugs, 2019, 37 : 473 - 481
12345